N-Acetyl Selank Amidate
Also known as: NA-Selank-Amidate
Enhanced formulation of Selank with N-Acetyl modification and amidation. Provides improved stability, longer-lasting anxiolytic effects, and enhanced nootropic properties.
Research Status
Limited Clinical Data
For research purposes only. Not approved for human use. Not medical advice.
Research Areas
Side Effects
May occur with intranasal administration. Typically resolves within minutes. Ensure nasal passages are clear before administration. Alternate nostrils with each dose.
Reported in some users, typically mild and transient. May be related to initial dosing or nasal irritation. Ensure adequate hydration.
Some users report mild sedation, particularly with higher doses or evening administration. Avoid driving or operating machinery if affected. Administer in the morning or early afternoon.
Rarely reported. May occur if solution drains to the throat. Keep head upright for 30 seconds after administration. Avoid eating immediately before or after dosing.
Discontinue immediately and seek medical attention if signs of allergic reaction develop. Individuals with peptide allergies or sensitivities should avoid use.
Some users report diminished effects with continuous daily use. Consider periodic breaks (e.g., 5 days on, 2 days off) or dose cycling to maintain efficacy.
Rare paradoxical response in sensitive individuals. Discontinue and consult a healthcare provider if this occurs.
Dosing Reference
| Parameter | Value |
|---|---|
| Dose range | 200-400 mcg |
| Frequency | 1-2x daily |
| Timing | Morning and/or afternoon; avoid evening dosing due to potential stimulant effects |
| Route | Subcutaneous |
Intranasal administration preferred for N-Acetyl Selank Amidate. Start at 200 mcg once daily and assess tolerance before increasing frequency. For research purposes only.
Research disclaimer
Figures drawn from published research literature and community logs. Not clinical recommendations. Consult a qualified professional. Research use only.
Reconstitution Guide
Do not use saline or bacteriostatic saline — use only bacteriostatic water for reconstitution
Do not shake the vial vigorously; gentle swirling prevents peptide degradation
Discard immediately if the solution appears cloudy, discolored, or contains visible particles
Use within 30 days of reconstitution when stored at 2–8°C
Do not freeze the reconstituted solution; freezing may denature the peptide
Use the PeptideVolt reconstitution calculator for your exact concentration
Molecular and Pharmacological Data
| Half-life | Extended compared to native Selank due to N-Acetyl modification and amidation; estimated 30-60 minutes in circulation |
N-Acetyl Selank Amidate is a synthetic heptapeptide derivative of the natural immunomodulatory peptide Selank. The N-Acetyl modification and amidation enhance metabolic stability and extend the peptide's half-life in circulation. It acts as a modulator of monoamine neurotransmitter systems (serotonin, dopamine, norepinephrine) and influences GABAergic signaling, producing anxiolytic and nootropic effects. The peptide also exhibits immunomodulatory properties through interactions with immune cell populations.
Monoamine Neurotransmitter Modulation
N-Acetyl Selank Amidate influences serotonin, dopamine, and norepinephrine systems in the brain, contributing to anxiolytic effects and mood enhancement. This modulation supports emotional regulation and stress resilience.
GABAergic Signaling
The peptide enhances GABAergic neurotransmission, the primary inhibitory system in the central nervous system, which promotes relaxation and reduces anxiety-related neural activity.
Immunomodulation
N-Acetyl Selank Amidate interacts with T-lymphocytes and other immune cells, modulating cytokine production and supporting immune homeostasis, which may indirectly support stress adaptation.
Neuroprotection
The peptide exhibits antioxidant and anti-inflammatory properties in neural tissue, supporting neuronal survival and cognitive function through reduced neuroinflammation.
- N-Acetyl modification increases resistance to enzymatic degradation, extending the peptide's duration of action
- Amidation at the C-terminus further stabilizes the peptide structure and enhances bioavailability
- Intranasal administration allows direct access to the central nervous system, bypassing the blood-brain barrier
- The peptide does not bind to opioid receptors, distinguishing it from other anxiolytic compounds
- Effects are typically observed within 15-30 minutes of intranasal administration
Track your N-Acetyl Selank Amidate research
Free account. No credit card required.
Browse the Research Library
40+ peptide profiles with mechanism summaries, dosing data, and reconstitution guides.
View all peptidesResearch Use Only. All content on this page is provided for informational and educational purposes related to scientific research. N-Acetyl Selank Amidate is not approved for human use by the FDA or any equivalent regulatory body. This is not medical advice. Do not use any substance discussed here for therapeutic, diagnostic, or preventative purposes. Consult a qualified healthcare professional before making any health-related decisions. The Peptide Volt does not endorse the use of any research chemicals. 18+ only.